Acadian Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.3M Buy
450,996
+316,977
+237% +$24.8M 0.07% 220
2025
Q1
$9.71M Buy
134,019
+88,099
+192% +$6.38M 0.03% 341
2024
Q4
$3.4M Buy
45,920
+1,487
+3% +$110K 0.01% 630
2024
Q3
$2.93M Sell
44,433
-44,370
-50% -$2.92M 0.01% 641
2024
Q2
$8.2M Buy
88,803
+72,458
+443% +$6.69M 0.03% 390
2024
Q1
$1.56M Sell
16,345
-24,197
-60% -$2.31M 0.01% 723
2023
Q4
$3.09M Buy
40,542
+26,977
+199% +$2.06M 0.01% 572
2023
Q3
$938K Sell
13,565
-18,729
-58% -$1.3M ﹤0.01% 866
2023
Q2
$3.04M Sell
32,294
-26,055
-45% -$2.46M 0.01% 583
2023
Q1
$4.82M Sell
58,349
-281,686
-83% -$23.3M 0.02% 464
2022
Q4
$25.4M Buy
340,035
+313,236
+1,169% +$23.4M 0.12% 176
2022
Q3
$2.21M Sell
26,799
-3,213
-11% -$265K 0.01% 609
2022
Q2
$2.85M Buy
30,012
+2,303
+8% +$219K 0.01% 542
2022
Q1
$3.26M Sell
27,709
-864
-3% -$102K 0.01% 555
2021
Q4
$3.7M Sell
28,573
-164,046
-85% -$21.2M 0.01% 528
2021
Q3
$21.8M Buy
192,619
+179,721
+1,393% +$20.3M 0.08% 201
2021
Q2
$1.34M Sell
12,898
-813
-6% -$84.2K 0.01% 828
2021
Q1
$1.15M Buy
13,711
+4,626
+51% +$387K ﹤0.01% 905
2020
Q4
$829K Sell
9,085
-3,318
-27% -$303K ﹤0.01% 1047
2020
Q3
$990K Sell
12,403
-78,539
-86% -$6.27M ﹤0.01% 918
2020
Q2
$6.29M Buy
+90,942
New +$6.29M 0.03% 438
2019
Q4
Sell
-9,690
Closed -$710K 1952
2019
Q3
$710K Buy
+9,690
New +$710K ﹤0.01% 995
2019
Q2
Sell
-7,410
Closed -$473K 1880
2019
Q1
$473K Buy
7,410
+4,638
+167% +$296K ﹤0.01% 1113
2018
Q4
$142K Buy
+2,772
New +$142K ﹤0.01% 1191
2016
Q3
Sell
-22,197
Closed -$737K 1463
2016
Q2
$737K Buy
+22,197
New +$737K ﹤0.01% 691
2015
Q3
Sell
-3,984
Closed -$95K 1334
2015
Q2
$95K Sell
3,984
-32,100
-89% -$765K ﹤0.01% 1021
2015
Q1
$858K Sell
36,084
-314,268
-90% -$7.47M ﹤0.01% 678
2014
Q4
$7.44M Buy
350,352
+335,910
+2,326% +$7.13M 0.03% 334
2014
Q3
$246K Buy
+14,442
New +$246K ﹤0.01% 751